XT
ARDS

XTX Topco’s Aridis Pharmaceuticals Inc. Common Stock ARDS Stock Holding History

XTX Topco’s Portfolio ARDS Stock Details ARDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-11,867
Closed -$21K – 1172
2022
Q1 		$21K Buy
+11,867
New +$22.5K 0.01% 628

Other funds holding ARDS

Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MWM
Minot Wealth Management Westwood, Massachusetts $389M AUM 3.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

XTX Topco's ARDS Position: Q2 2022 in Review

XTX Topco sold out of Aridis Pharmaceuticals Inc. Common Stock (ARDS) in Q2 2022, closing a stake of 11,867 shares — an estimated $21K sold.

XTX Topco first reported a position in ARDS in Q1 2022 and held it in 1 quarter. The position peaked at $21K in Q1 2022. 19 funds tracked by Wall St. Rank hold ARDS as of Q2 2022.

  • XTX Topco reported no remaining Aridis Pharmaceuticals Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • XTX Topco sold 11,867 Aridis Pharmaceuticals Inc. Common Stock shares in Q2 2022, an estimated $21K.
  • XTX Topco first reported a position in Aridis Pharmaceuticals Inc. Common Stock in Q1 2022 and held it in 1 quarter.
  • XTX Topco's Aridis Pharmaceuticals Inc. Common Stock position peaked at $21K in Q1 2022.
  • 19 funds tracked by Wall St. Rank held Aridis Pharmaceuticals Inc. Common Stock as of Q2 2022.

Based on XTX Topco's 13F filing for Q2 2022, filed 15 Aug 2022.